Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Operating Expenses (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Operating Expenses for 16 consecutive years, with $19.5 million as the latest value for Q3 2025.

  • Quarterly Operating Expenses fell 3.15% to $19.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $76.2 million through Sep 2025, down 8.56% year-over-year, with the annual reading at $80.3 million for FY2024, 22.35% up from the prior year.
  • Operating Expenses for Q3 2025 was $19.5 million at Xtant Medical Holdings, down from $19.7 million in the prior quarter.
  • The five-year high for Operating Expenses was $21.5 million in Q2 2024, with the low at $8.1 million in Q1 2021.
  • Average Operating Expenses over 5 years is $14.7 million, with a median of $13.8 million recorded in 2023.
  • The sharpest move saw Operating Expenses decreased 26.24% in 2021, then skyrocketed 108.8% in 2023.
  • Over 5 years, Operating Expenses stood at $9.6 million in 2021, then increased by 4.41% to $10.0 million in 2022, then skyrocketed by 108.8% to $20.9 million in 2023, then fell by 14.5% to $17.9 million in 2024, then rose by 8.63% to $19.5 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $19.5 million, $19.7 million, and $19.2 million for Q3 2025, Q2 2025, and Q1 2025 respectively.